Microspectroscopy (μFTIR) reveals co-localization of lipid oxidation and amyloid plaques in human Alzheimer disease brains

Amyloid peptides are the main component of one of the characteristic pathological hallmarks of Alzheimer's disease (AD): senile plaques. According to the amyloid cascade hypothesis, amyloid peptides may play a central role in the sequence of events that leads to neurodegeneration. However, ther...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Analytical chemistry (Washington) Ročník 86; číslo 24; s. 12047
Hlavní autoři: Benseny-Cases, Núria, Klementieva, Oxana, Cotte, Marine, Ferrer, Isidre, Cladera, Josep
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 16.12.2014
Témata:
ISSN:1520-6882, 1520-6882
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Amyloid peptides are the main component of one of the characteristic pathological hallmarks of Alzheimer's disease (AD): senile plaques. According to the amyloid cascade hypothesis, amyloid peptides may play a central role in the sequence of events that leads to neurodegeneration. However, there are other factors, such as oxidative stress, that may be crucial for the development of the disease. In the present paper, we show that it is possible, by using Fourier tranform infrared (FTIR) microscopy, to co-localize amyloid deposits and lipid peroxidation in tissue slides from patients affected by Alzheimer's disease. Plaques and lipids can be analyzed in the same sample, making use of the characteristic infrared bands for peptide aggregation and lipid oxidation. The results show that, in samples from patients diagnosed with AD, the plaques and their immediate surroundings are always characterized by the presence of oxidized lipids. As for samples from non-AD individuals, those without amyloid plaques show a lower level of lipid oxidation than AD individuals. However, it is known that plaques can be detected in the brains of some non-AD individuals. Our results show that, in such cases, the lipid in the plaques and their surroundings display oxidation levels that are similar to those of tissues with no plaques. These results point to lipid oxidation as a possible key factor in the path that goes from showing the typical neurophatological hallmarks to suffering from dementia. In this process, the oxidative power of the amyloid peptide, possibly in the form of nonfibrillar aggregates, could play a central role.
AbstractList Amyloid peptides are the main component of one of the characteristic pathological hallmarks of Alzheimer's disease (AD): senile plaques. According to the amyloid cascade hypothesis, amyloid peptides may play a central role in the sequence of events that leads to neurodegeneration. However, there are other factors, such as oxidative stress, that may be crucial for the development of the disease. In the present paper, we show that it is possible, by using Fourier tranform infrared (FTIR) microscopy, to co-localize amyloid deposits and lipid peroxidation in tissue slides from patients affected by Alzheimer's disease. Plaques and lipids can be analyzed in the same sample, making use of the characteristic infrared bands for peptide aggregation and lipid oxidation. The results show that, in samples from patients diagnosed with AD, the plaques and their immediate surroundings are always characterized by the presence of oxidized lipids. As for samples from non-AD individuals, those without amyloid plaques show a lower level of lipid oxidation than AD individuals. However, it is known that plaques can be detected in the brains of some non-AD individuals. Our results show that, in such cases, the lipid in the plaques and their surroundings display oxidation levels that are similar to those of tissues with no plaques. These results point to lipid oxidation as a possible key factor in the path that goes from showing the typical neurophatological hallmarks to suffering from dementia. In this process, the oxidative power of the amyloid peptide, possibly in the form of nonfibrillar aggregates, could play a central role.
Amyloid peptides are the main component of one of the characteristic pathological hallmarks of Alzheimer's disease (AD): senile plaques. According to the amyloid cascade hypothesis, amyloid peptides may play a central role in the sequence of events that leads to neurodegeneration. However, there are other factors, such as oxidative stress, that may be crucial for the development of the disease. In the present paper, we show that it is possible, by using Fourier tranform infrared (FTIR) microscopy, to co-localize amyloid deposits and lipid peroxidation in tissue slides from patients affected by Alzheimer's disease. Plaques and lipids can be analyzed in the same sample, making use of the characteristic infrared bands for peptide aggregation and lipid oxidation. The results show that, in samples from patients diagnosed with AD, the plaques and their immediate surroundings are always characterized by the presence of oxidized lipids. As for samples from non-AD individuals, those without amyloid plaques show a lower level of lipid oxidation than AD individuals. However, it is known that plaques can be detected in the brains of some non-AD individuals. Our results show that, in such cases, the lipid in the plaques and their surroundings display oxidation levels that are similar to those of tissues with no plaques. These results point to lipid oxidation as a possible key factor in the path that goes from showing the typical neurophatological hallmarks to suffering from dementia. In this process, the oxidative power of the amyloid peptide, possibly in the form of nonfibrillar aggregates, could play a central role.Amyloid peptides are the main component of one of the characteristic pathological hallmarks of Alzheimer's disease (AD): senile plaques. According to the amyloid cascade hypothesis, amyloid peptides may play a central role in the sequence of events that leads to neurodegeneration. However, there are other factors, such as oxidative stress, that may be crucial for the development of the disease. In the present paper, we show that it is possible, by using Fourier tranform infrared (FTIR) microscopy, to co-localize amyloid deposits and lipid peroxidation in tissue slides from patients affected by Alzheimer's disease. Plaques and lipids can be analyzed in the same sample, making use of the characteristic infrared bands for peptide aggregation and lipid oxidation. The results show that, in samples from patients diagnosed with AD, the plaques and their immediate surroundings are always characterized by the presence of oxidized lipids. As for samples from non-AD individuals, those without amyloid plaques show a lower level of lipid oxidation than AD individuals. However, it is known that plaques can be detected in the brains of some non-AD individuals. Our results show that, in such cases, the lipid in the plaques and their surroundings display oxidation levels that are similar to those of tissues with no plaques. These results point to lipid oxidation as a possible key factor in the path that goes from showing the typical neurophatological hallmarks to suffering from dementia. In this process, the oxidative power of the amyloid peptide, possibly in the form of nonfibrillar aggregates, could play a central role.
Author Klementieva, Oxana
Cotte, Marine
Benseny-Cases, Núria
Cladera, Josep
Ferrer, Isidre
Author_xml – sequence: 1
  givenname: Núria
  surname: Benseny-Cases
  fullname: Benseny-Cases, Núria
  organization: European Synchrotron Radiation Facility, 71 Avenue des Martyrs, F-38000 Grenoble, France
– sequence: 2
  givenname: Oxana
  surname: Klementieva
  fullname: Klementieva, Oxana
– sequence: 3
  givenname: Marine
  surname: Cotte
  fullname: Cotte, Marine
– sequence: 4
  givenname: Isidre
  surname: Ferrer
  fullname: Ferrer, Isidre
– sequence: 5
  givenname: Josep
  surname: Cladera
  fullname: Cladera, Josep
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25415602$$D View this record in MEDLINE/PubMed
BookMark eNpNkN1KwzAcxYNM3Ide-AKSy3lRTdImTS_HcDqYCDKvy79JyiJpU5tO3Hw1n8FnsrIJXp3D4cfhcMZoUPvaIHRJyQ0ljN6C4oQJkRYnaEQ5I5GQkg3--SEah_BKCKWEijM0ZDyhXBA2Qp-PVrU-NEZ1vSjf7PD0-2uxXj5f49a8G3ABKx85r8DZPXTW19iX2NnGauw_rD5EUGsM1c75Pm0cvG1NwLbGm20FNZ65_cbYyrRY22AgGFy0YOtwjk7Lvt9cHHWCXhZ36_lDtHq6X85nqwg4JV2UcSNkATKhpgBOtCwyrqmQGWSphLhUQDRJMwKppLGkSsZKZ0miFGhKRBmzCZoeepvW_y7r8soGZZyD2vhtyKmIU86lkKxHr47otqiMzpvWVtDu8r_D2A_VlXA9
CitedBy_id crossref_primary_10_1016_j_cca_2019_01_021
crossref_primary_10_1007_s12035_024_04388_x
crossref_primary_10_1038_s41598_019_50837_2
crossref_primary_10_1038_s41598_024_82999_z
crossref_primary_10_1038_s41598_017_11721_z
crossref_primary_10_3390_ijms21041505
crossref_primary_10_1007_s10043_018_0416_5
crossref_primary_10_3390_ijms22073430
crossref_primary_10_1016_j_joim_2025_02_001
crossref_primary_10_1016_j_vibspec_2016_09_016
crossref_primary_10_1016_j_jep_2023_117132
crossref_primary_10_1039_C6AN01580H
crossref_primary_10_1038_s42003_024_07034_3
crossref_primary_10_1038_ncomms14726
crossref_primary_10_1039_C6CS00542J
crossref_primary_10_1111_jnc_16306
crossref_primary_10_1155_2016_9245150
crossref_primary_10_3233_BSI_170171
crossref_primary_10_1186_s12964_018_0277_3
crossref_primary_10_1016_j_infrared_2025_106138
crossref_primary_10_1007_s11356_018_3726_z
crossref_primary_10_1016_j_saa_2019_117570
crossref_primary_10_1186_s40409_017_0114_y
crossref_primary_10_1016_j_vibspec_2016_07_017
crossref_primary_10_1038_s41598_021_96379_4
crossref_primary_10_3389_fnins_2018_00647
crossref_primary_10_1016_j_saa_2020_118625
crossref_primary_10_1016_j_saa_2021_120794
crossref_primary_10_1111_bpa_13202
crossref_primary_10_3389_fcell_2021_704298
crossref_primary_10_1016_j_crci_2016_05_011
crossref_primary_10_3390_diagnostics11112133
crossref_primary_10_1038_s41377_021_00590_x
crossref_primary_10_3390_ijms242216353
crossref_primary_10_3389_fnagi_2023_1266859
crossref_primary_10_3389_fphar_2025_1588375
crossref_primary_10_1371_journal_pbio_3001358
crossref_primary_10_1016_j_nano_2022_102563
crossref_primary_10_1016_j_nbd_2016_03_006
crossref_primary_10_1080_17435390_2017_1342011
crossref_primary_10_1016_j_biopha_2023_115656
crossref_primary_10_1016_j_cclet_2025_111628
crossref_primary_10_1039_C7AN01904A
crossref_primary_10_1016_j_arr_2024_102599
crossref_primary_10_3390_antiox9080649
crossref_primary_10_1002_jbio_202000303
crossref_primary_10_1016_j_carbpol_2024_121815
crossref_primary_10_1016_j_cca_2019_07_037
crossref_primary_10_1038_s41377_023_01191_6
crossref_primary_10_3390_ijms22031206
crossref_primary_10_1007_s11011_025_01587_w
crossref_primary_10_1038_s41598_024_59165_6
crossref_primary_10_1039_C6AN01797E
crossref_primary_10_3390_cells10082127
crossref_primary_10_1016_j_desal_2025_119243
crossref_primary_10_3389_fnins_2022_823741
crossref_primary_10_3390_ijms25105317
crossref_primary_10_1021_jacs_3c08854
crossref_primary_10_3390_photonics4020032
crossref_primary_10_1016_j_saa_2018_12_054
crossref_primary_10_1016_j_heliyon_2025_e42111
crossref_primary_10_1186_s40478_020_01091_5
crossref_primary_10_1038_s41467_019_09111_2
crossref_primary_10_3389_fncel_2023_1223912
crossref_primary_10_1016_j_bbrc_2025_152583
crossref_primary_10_3390_biom10081099
crossref_primary_10_1016_j_pneurobio_2024_102572
crossref_primary_10_1016_j_bbagen_2024_130688
crossref_primary_10_1038_s41598_020_62708_2
crossref_primary_10_3390_ijms232012631
crossref_primary_10_1177_13872877251319553
crossref_primary_10_1111_febs_16344
crossref_primary_10_1186_s40478_021_01259_7
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/ac502667b
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Engineering
Chemistry
EISSN 1520-6882
ExternalDocumentID 25415602
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
.DC
.K2
23M
4.4
53G
55A
5GY
5RE
5VS
6J9
7~N
85S
AABXI
AAHBH
ABBLG
ABHFT
ABHMW
ABJNI
ABLBI
ABMVS
ABOCM
ABPPZ
ABQRX
ABUCX
ACBEA
ACGFO
ACGFS
ACGOD
ACIWK
ACJ
ACKOT
ACNCT
ACPRK
ACS
ADHLV
AEESW
AENEX
AFEFF
AFRAH
AGXLV
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
BKOMP
CGR
CS3
CUPRZ
CUY
CVF
D0L
EBS
ECM
ED~
EIF
EJD
F5P
GGK
GNL
IH9
IHE
JG~
KZ1
LG6
LMP
NPM
P2P
PQQKQ
ROL
RXW
TAE
TN5
UHB
UI2
UKR
VF5
VG9
W1F
WH7
X6Y
XSW
YZZ
ZCA
~02
7X8
ID FETCH-LOGICAL-a510t-95e68ba841eba50d8b95d1689a978a3fca0d0790a781381c83cd944ccad106f32
IEDL.DBID 7X8
ISICitedReferencesCount 95
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000346683900021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1520-6882
IngestDate Thu Oct 02 09:43:02 EDT 2025
Mon Jul 21 05:49:56 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 24
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a510t-95e68ba841eba50d8b95d1689a978a3fca0d0790a781381c83cd944ccad106f32
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://zenodo.org/record/3424006
PMID 25415602
PQID 1637558682
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1637558682
pubmed_primary_25415602
PublicationCentury 2000
PublicationDate 2014-12-16
PublicationDateYYYYMMDD 2014-12-16
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12-16
  day: 16
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Analytical chemistry (Washington)
PublicationTitleAlternate Anal Chem
PublicationYear 2014
SSID ssj0011016
Score 2.4845216
Snippet Amyloid peptides are the main component of one of the characteristic pathological hallmarks of Alzheimer's disease (AD): senile plaques. According to the...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 12047
SubjectTerms Alzheimer Disease - pathology
Brain Chemistry
Humans
Immunohistochemistry - instrumentation
Immunohistochemistry - methods
Lipids - chemistry
Oxidation-Reduction
Plaque, Amyloid - chemistry
Spectroscopy, Fourier Transform Infrared
Title Microspectroscopy (μFTIR) reveals co-localization of lipid oxidation and amyloid plaques in human Alzheimer disease brains
URI https://www.ncbi.nlm.nih.gov/pubmed/25415602
https://www.proquest.com/docview/1637558682
Volume 86
WOSCitedRecordID wos000346683900021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LSsNAFB3UCurC96O-GMGFLkLzzmQlpVgUbClSobswr2CgTWJTxcev-Q1-k3cmCXUjCG6yCCQMNzdzz5k7cw5C54xDEXABuVHXNw3XlpbBiOsYjBMo5iRmDtMirndBv09Go3BQLbgV1bbKek7UE7XIuFojbwFuCDyP-MS-yp8M5RqluquVhcYiajgAZVRWB6N5F0ExU62XqigSQMlaWci2WpR7wD78gP2OLHWF6W78d2ybaL3ClrhdJsMWWpDpNlrp1JZu22jth_rgDvroqc14-qilkrTM8jd88fXZHd7eX2Il7ASJiXlm6GpXndbEWYzHSZ4InL0mpRsTpqnAdAK8H-7mY6rGjZMUa_M_3B6_P8pkIqe46gRhpjwpil300L0edm6MyovBoPDXzozQkz5hlLiWZNQzBWGhJyyfhBRoKHViTk1hBqFJA2IBCODE4SJ0XcgPAaQzduw9tJRmqTxAGKJFGTVdpqT2gQFRLiwBLJNwbsILrCY6q6McQXxUA4OmMnsuonmcm2i__FRRXopyREB01aFw-_APTx-hVcA9Wq_R8o9RI4aAyhO0zF9mSTE91UkE1_6g9w33btPr
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Microspectroscopy+%28%CE%BCFTIR%29+reveals+co-localization+of+lipid+oxidation+and+amyloid+plaques+in+human+Alzheimer+disease+brains&rft.jtitle=Analytical+chemistry+%28Washington%29&rft.au=Benseny-Cases%2C+N%C3%BAria&rft.au=Klementieva%2C+Oxana&rft.au=Cotte%2C+Marine&rft.au=Ferrer%2C+Isidre&rft.date=2014-12-16&rft.eissn=1520-6882&rft.volume=86&rft.issue=24&rft.spage=12047&rft_id=info:doi/10.1021%2Fac502667b&rft_id=info%3Apmid%2F25415602&rft_id=info%3Apmid%2F25415602&rft.externalDocID=25415602
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1520-6882&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1520-6882&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1520-6882&client=summon